Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion

Fecha de publicación: 29 de octubre de 2026, 16:46

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.